EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The differences between pure and mixed invasive micropapillary breast cancer: the epithelial–mesenchymal transition molecules and prognosis

Ozden Oz, Resmiye Irmak Yuzuguldu, Ayse Yazici, Demet Kocatepe Cavdar, Cengiz Yilmaz, Mucteba Ozturk, Hilal Duzel, Duygu Gurel

Breast Cancer Research and Treatment · 2024

DOI: 10.1007/s10549-024-07384-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Ozden Oz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Izmir Bozyaka Training and Research Hospital, University of Health Sciences, Izmir, Turkey. ozdenozpat@gmail.com. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dokuz Eylül University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Invasive micropapillary carcinoma (IMPC) of the breast is known for its high metastatic potential, but the definition of pure and mixed IMPC remains unclear. This retrospective cohort study aims to investigate the prognostic significance of the micropapillary component ratio and the expression of critical molecules of epithelial–mesenchymal transition (EMT), including E-cadherin (E-cad), N-cadherin (N-cad), CD44s, and β-catenin (β-cat), in distinguishing between pure and mixed IMPCs.

Methods

We analyzed 100 cases of locally advanced IMPC between 2000 and 2018 and excluded patients who received neoadjuvant chemotherapy. Pure IMPC was defined as having a micropapillary component of over 90%. A comprehensive recording of prognostic parameters was conducted. The IMPC areas were analyzed using the immunohistochemical (IHC) staining method on the microarray set for pure and mixed IMPC patients. Pearson's chi-square, Fisher’s exact tests, Kaplan–Meier analysis, and Cox proportional hazards analysis were employed.

Results

The comparative survival analysis of the entire group, based on overall survival (OS) and disease-free survival (DFS), revealed no significant difference between the pure and mixed groups ( P = 0.480, HR = 1.474 [0.502–4.325] and P = 0.390, HR = 1.587 [0.550–4.640], respectively). However, in the pure IMPC group, certain factors were found to be associated with a higher risk of short survival. These factors included skin involvement ( P = 0.050), pT3&4 category ( P = 0.006), a ratio of intraductal component (> 5%) ( P = 0.032), and high-level expression of N-cad ( P = 0.020). Notably, none of the risk factors identified for short OS in pure IMPC cases were observed as significant risks in mixed cases and vice versa. Furthermore, N-cad was identified as a poor prognostic marker for OS in pure IMPCs ( P = 0.002).

Conclusion

The selection of a 90% ratio for classifying pure IMPCs revealed significant differences in certain molecular and prognostic parameters between pure and mixed groups. Notably, the involvement of N-cadherin in the epithelial–mesenchymal transition (EMT) process provided crucial insights for predicting OS and DFS while also distinguishing between the two groups. These findings strongly support the notion that the pure IMPC subgroup represents a distinct entity characterized by unique molecular characteristics and behavioral patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionBreast NeoplasmsBiomarkers, TumorHumansFemaleMiddle AgedPrognosisRetrospective StudiesAgedAdultCadherinsCarcinoma, Papillarybeta CateninHyaluronan ReceptorsKaplan-Meier Estimate

Stichwörter der Autor:innen

Epithelial–mesenchymal transition (EMT)PrognosisPrognostic parametersPure breast micropapillary carcinoma

Substanzen

Biomarkers, TumorCadherinsbeta CateninHyaluronan ReceptorsCTNNB1 protein, human

Autor:innen und Institutionen

  • Department of Pathology, Izmir Bozyaka Training and Research Hospital, University of Health Sciences, Izmir, Turkey. ozdenozpat@gmail.com.
  • Department of Pathology, Mugla Training and Research Hospital, Mugla, Turkey.
  • Department of Pathology, Faculty of Medicine, Training and Research Hospital, Izmir Katip Celebi University, Izmir, Turkey.
  • Department of Pathology, Izmir Bozyaka Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
  • Department of Medical Oncology, Izmir Bozyaka Training and Research Hospital, University of Health Sciences, Izmir, Turkey.
  • Department of General Surgery, Izmir Bozyaka Training and Research Hospital, University of Health Sciences, Izmir, Turkey.

Förderung

  • Dokuz Eylül University

Zitieren

APA

Oz, O., Irmak Yuzuguldu, R., Yazici, A., Kocatepe Cavdar, D., Yilmaz, C., Ozturk, M., Duzel, H., & Gurel, D. (2024). The differences between pure and mixed invasive micropapillary breast cancer: the epithelial–mesenchymal transition molecules and prognosis. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07384-w

Vancouver

Oz O, Irmak Yuzuguldu R, Yazici A, Kocatepe Cavdar D, Yilmaz C, Ozturk M, et al. The differences between pure and mixed invasive micropapillary breast cancer: the epithelial–mesenchymal transition molecules and prognosis. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07384-w

BibTeX
@article{Oz2024,
  author = {Oz, Ozden and Irmak Yuzuguldu, Resmiye and Yazici, Ayse and Kocatepe Cavdar, Demet and Yilmaz, Cengiz and Ozturk, Mucteba and Duzel, Hilal and Gurel, Duygu},
  title = {The differences between pure and mixed invasive micropapillary breast cancer: the epithelial–mesenchymal transition molecules and prognosis},
  journal = {Breast Cancer Research and Treatment},
  year = {2024},
  doi = {10.1007/s10549-024-07384-w}
}
Kostenlos starten →